290 related articles for article (PubMed ID: 3745955)
1. Growth factor and cytogenetic abnormalities in cultured nevi and malignant melanomas.
Richmond A; Fine R; Murray D; Lawson DH; Priest JH
J Invest Dermatol; 1986 Mar; 86(3):295-302. PubMed ID: 3745955
[TBL] [Abstract][Full Text] [Related]
2. Cytogenetics of human malignant melanoma and premalignant lesions.
Balaban G; Herlyn M; Guerry D; Bartolo R; Koprowski H; Clark WH; Nowell PC
Cancer Genet Cytogenet; 1984 Apr; 11(4):429-39. PubMed ID: 6584203
[TBL] [Abstract][Full Text] [Related]
3. BRAF and NRAS mutations in melanoma and melanocytic nevi.
Poynter JN; Elder JT; Fullen DR; Nair RP; Soengas MS; Johnson TM; Redman B; Thomas NE; Gruber SB
Melanoma Res; 2006 Aug; 16(4):267-73. PubMed ID: 16845322
[TBL] [Abstract][Full Text] [Related]
4. IMP-3 EXPRESSION IN BENIGN MELANOCYTIC NEVI, DYSPLASTIC NEVI AND MALIGNANT MELANOMA: PRELIMINARY FINDINGS IN BULGARIAN PATIENTS.
Chokoeva AA; Ananiev J; Wollina U; Tana C; Lotti T; Cardoso JC; Tchernev G
J Biol Regul Homeost Agents; 2015; 29(3):695-9. PubMed ID: 26403409
[TBL] [Abstract][Full Text] [Related]
5. Tumor progression in the human melanocytic system.
Kath R; Rodeck U; Menssen HD; Mancianti ML; Linnenbach AJ; Elder DE; Herlyn M
Anticancer Res; 1989; 9(4):865-72. PubMed ID: 2554787
[TBL] [Abstract][Full Text] [Related]
6. Staining of melanocytic neoplasms by melanoma antigen recognized by T cells.
Mehregan DR; Hamzavi I
Am J Dermatopathol; 2000 Jun; 22(3):247-50. PubMed ID: 10871068
[TBL] [Abstract][Full Text] [Related]
7. Deep penetrating nevus-like borderline tumors: A unique subset of ambiguous melanocytic tumors with malignant potential and normal cytogenetics.
Magro CM; Abraham RM; Guo R; Li S; Wang X; Proper S; Crowson AN; Mihm M
Eur J Dermatol; 2014; 24(5):594-602. PubMed ID: 25118781
[TBL] [Abstract][Full Text] [Related]
8. Genetic changes in neoplasms arising in congenital melanocytic nevi: differences between nodular proliferations and melanomas.
Bastian BC; Xiong J; Frieden IJ; Williams ML; Chou P; Busam K; Pinkel D; LeBoit PE
Am J Pathol; 2002 Oct; 161(4):1163-9. PubMed ID: 12368190
[TBL] [Abstract][Full Text] [Related]
9. Classifying melanocytic tumors based on DNA copy number changes.
Bastian BC; Olshen AB; LeBoit PE; Pinkel D
Am J Pathol; 2003 Nov; 163(5):1765-70. PubMed ID: 14578177
[TBL] [Abstract][Full Text] [Related]
10. Patterns of melastatin mRNA expression in melanocytic tumors.
Deeds J; Cronin F; Duncan LM
Hum Pathol; 2000 Nov; 31(11):1346-56. PubMed ID: 11112208
[TBL] [Abstract][Full Text] [Related]
11. Atypical melanocytic nevi of the genital type with a discussion of reciprocal parenchymal-stromal interactions in the biology of neoplasia.
Clark WH; Hood AF; Tucker MA; Jampel RM
Hum Pathol; 1998 Jan; 29(1 Suppl 1):S1-24. PubMed ID: 9445124
[TBL] [Abstract][Full Text] [Related]
12. Expression of insulin-like growth factor-binding protein 2 in melanocytic lesions.
Wang H; Shen SS; Wang H; Diwan AH; Zhang W; Fuller GN; Prieto VG
J Cutan Pathol; 2003 Nov; 30(10):599-605. PubMed ID: 14744083
[TBL] [Abstract][Full Text] [Related]
13. Malignant melanoma arising in a giant congenital melanocytic nevus. A case report with cytogenetic and histopathologic analyses.
Padilla RS; McConnell TS; Gribble JT; Smoot C
Cancer; 1988 Dec; 62(12):2589-94. PubMed ID: 3191458
[TBL] [Abstract][Full Text] [Related]
14. Differentiation between Spitz nevi and malignant melanomas by interphase fluorescence in situ hybridization.
Wettengel GV; Draeger J; Kiesewetter F; Schell H; Neubauer S; Gebhart E
Int J Oncol; 1999 Jun; 14(6):1177-83. PubMed ID: 10339676
[TBL] [Abstract][Full Text] [Related]
15. Cytogenetic analysis of melanocytes from premalignant nevi and melanomas.
Cowan JM; Halaban R; Francke U
J Natl Cancer Inst; 1988 Sep; 80(14):1159-64. PubMed ID: 3166071
[TBL] [Abstract][Full Text] [Related]
16. Allelotypes of primary cutaneous melanoma and benign melanocytic nevi.
Healy E; Belgaid CE; Takata M; Vahlquist A; Rehman I; Rigby H; Rees JL
Cancer Res; 1996 Feb; 56(3):589-93. PubMed ID: 8564976
[TBL] [Abstract][Full Text] [Related]
17. Alteration of chromosome 9p21 and/or p16 in benign and dysplastic nevi suggests a role in early melanoma progression (United States).
Tran TP; Titus-Ernstoff L; Perry AE; Ernstoff MS; Newsham IF
Cancer Causes Control; 2002 Sep; 13(7):675-82. PubMed ID: 12296515
[TBL] [Abstract][Full Text] [Related]
18. Fluorescence in situ hybridization as a tool for microstaging in malignant melanoma.
Newman MD; Lertsburapa T; Mirzabeigi M; Mafee M; Guitart J; Gerami P
Mod Pathol; 2009 Aug; 22(8):989-95. PubMed ID: 19448594
[TBL] [Abstract][Full Text] [Related]
19. Expression of the embryonic morphogen Nodal in cutaneous melanocytic lesions.
Yu L; Harms PW; Pouryazdanparast P; Kim DS; Ma L; Fullen DR
Mod Pathol; 2010 Sep; 23(9):1209-14. PubMed ID: 20495543
[TBL] [Abstract][Full Text] [Related]
20. Fluorescence in situ hybridization for distinguishing nevoid melanomas from mitotically active nevi.
Gerami P; Wass A; Mafee M; Fang Y; Pulitzer MP; Busam KJ
Am J Surg Pathol; 2009 Dec; 33(12):1783-8. PubMed ID: 19809275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
